AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. TNDM
  4. [Form 4] Tandem Diabetes Care, Inc. Insider Trading Activity

[Form 4] Tandem Diabetes Care, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 24 June 2025, Southside Bancshares Inc. (SBSI) filed a Form 4 reporting a minor insider transaction by Chief Banking Officer Sherri Anthony. On 20 June 2025, Anthony disposed of 121 common shares at an average price of $27.97 under transaction code F, which typically denotes shares withheld to cover taxes or exercise costs. After the sale, she directly owns 2,937 shares and indirectly holds 550 shares through the company ESOP. No derivative securities or additional transactions were disclosed.

The divestiture represents a very small fraction of both the executive鈥檚 total holdings and SBSI鈥檚 overall share count, suggesting minimal financial or market impact.

Il 24 giugno 2025, Southside Bancshares Inc. (SBSI) ha presentato un Modulo 4 riportando una piccola transazione interna effettuata dal Chief Banking Officer Sherri Anthony. Il 20 giugno 2025, Anthony ha ceduto 121 azioni ordinarie a un prezzo medio di 27,97 $ con codice transazione F, che solitamente indica azioni trattenute per coprire tasse o costi di esercizio. Dopo la vendita, possiede direttamente 2.937 azioni e detiene indirettamente 550 azioni tramite l'ESOP aziendale. Non sono stati dichiarati titoli derivati o altre transazioni.

La cessione rappresenta una frazione molto piccola sia del totale delle azioni detenute dall鈥檈secutivo sia del numero complessivo di azioni SBSI, suggerendo un impatto finanziario o di mercato minimo.

El 24 de junio de 2025, Southside Bancshares Inc. (SBSI) present贸 un Formulario 4 reportando una peque帽a transacci贸n interna realizada por la Directora de Banca, Sherri Anthony. El 20 de junio de 2025, Anthony vendi贸 121 acciones comunes a un precio promedio de 27,97 $ bajo el c贸digo de transacci贸n F, que generalmente indica acciones retenidas para cubrir impuestos o costos de ejercicio. Tras la venta, posee directamente 2.937 acciones y mantiene indirectamente 550 acciones a trav茅s del ESOP de la empresa. No se divulgaron valores derivados ni transacciones adicionales.

La desinversi贸n representa una fracci贸n muy peque帽a tanto de la tenencia total del ejecutivo como del total de acciones de SBSI, lo que sugiere un impacto financiero o de mercado m铆nimo.

2025雲� 6鞗� 24鞚�, Southside Bancshares Inc. (SBSI)電� 斓滉碃鞚�頄夓眳鞛勳瀽 Sherri Anthony鞚� 靻岅窚氇� 雮措秬鞛� 瓯半灅毳� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟. 2025雲� 6鞗� 20鞚�, Anthony電� 瓯半灅 旖旊摐 F鞐� 霐半澕 韽夑窢 臧�瓴� 27.97雼煬鞐� 121欤�鞚� 氤错喌欤茧ゼ 觳橂秳頄堨溂氅�, 鞚措姅 鞚茧皹鞝侅溂搿� 靹戈笀 霕愲姅 頄夓偓 牍勳毄鞚� 於╇嫻頃橁赴 鞙勴暣 欤检嫕鞚� 氤措頃橂姅 瓴冹潉 鞚橂頃╇媹雼�. 毵る弰 頉� 攴鸽厐電� 歆侅爲鞝侅溂搿� 2,937欤�毳� 氤挫湢頃橁碃 鞛堨溂氅� 須岇偓 ESOP毳� 韱淀暣 臧勳爲鞝侅溂搿� 550欤�毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 韺岇儩 歃濌秾鞚措倶 於旉皜 瓯半灅電� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

鞚措矆 毵り皝鞚� 鞛勳洂鞚� 齑� 氤挫湢 欤检嫕瓿� SBSI 鞝勳泊 欤检嫕 靾橃潣 鞎勳＜ 鞛戩潃 鞚茧秬毳� 彀頃橂┌, 鞛鞝� 霕愲姅 鞁滌灔鞐� 氙胳箻電� 鞓來枼鞚� 瓯办潣 鞐嗠嫟瓿� 韺愲嫧霅╇媹雼�.

Le 24 juin 2025, Southside Bancshares Inc. (SBSI) a d茅pos茅 un formulaire 4 signalant une transaction interne mineure r茅alis茅e par la directrice bancaire Sherri Anthony. Le 20 juin 2025, Anthony a c茅d茅 121 actions ordinaires 脿 un prix moyen de 27,97 $ sous le code de transaction F, qui indique g茅n茅ralement des actions retenues pour couvrir les imp么ts ou les co没ts d鈥檈xercice. Apr猫s la vente, elle d茅tient directement 2 937 actions et indirectement 550 actions via le plan ESOP de la soci茅t茅. Aucune valeur d茅riv茅e ni transaction suppl茅mentaire n鈥檃 茅t茅 divulgu茅e.

La cession repr茅sente une tr猫s faible fraction tant des avoirs totaux de la dirigeante que du nombre total d鈥檃ctions de SBSI, sugg茅rant un impact financier ou de march茅 minimal.

Am 24. Juni 2025 reichte Southside Bancshares Inc. (SBSI) ein Formular 4 ein, das eine kleinere Insider-Transaktion der Chief Banking Officer Sherri Anthony meldet. Am 20. Juni 2025 ver盲u脽erte Anthony 121 Stammaktien zu einem Durchschnittspreis von 27,97 $ unter dem Transaktionscode F, der 眉blicherweise f眉r zur眉ckbehaltene Aktien zur Deckung von Steuern oder Aus眉bungskosten steht. Nach dem Verkauf besitzt sie direkt 2.937 Aktien und h盲lt indirekt 550 Aktien 眉ber den ESOP des Unternehmens. Es wurden keine Derivate oder weiteren Transaktionen offengelegt.

Der Verkauf stellt einen sehr kleinen Anteil sowohl an den Gesamtbest盲nden der F眉hrungskraft als auch an der Gesamtzahl der SBSI-Aktien dar, was auf eine minimale finanzielle oder marktliche Auswirkung hindeutet.

Positive
  • None.
Negative
  • None.

Insights

Small tax-related share disposal; negligible impact on SBSI investors.

The Form 4 shows Chief Banking Officer Sherri Anthony relinquished only 121 shares鈥攔oughly a bookkeeping entry for tax withholding (code F). Her remaining stake of 2,937 direct shares plus 550 ESOP shares indicates continued alignment with shareholder interests. The transaction size is immaterial relative to Southside Bancshares鈥� daily trading volume and market capitalization, so no valuation effect is expected. I rate the filing as informational rather than actionable.

Il 24 giugno 2025, Southside Bancshares Inc. (SBSI) ha presentato un Modulo 4 riportando una piccola transazione interna effettuata dal Chief Banking Officer Sherri Anthony. Il 20 giugno 2025, Anthony ha ceduto 121 azioni ordinarie a un prezzo medio di 27,97 $ con codice transazione F, che solitamente indica azioni trattenute per coprire tasse o costi di esercizio. Dopo la vendita, possiede direttamente 2.937 azioni e detiene indirettamente 550 azioni tramite l'ESOP aziendale. Non sono stati dichiarati titoli derivati o altre transazioni.

La cessione rappresenta una frazione molto piccola sia del totale delle azioni detenute dall鈥檈secutivo sia del numero complessivo di azioni SBSI, suggerendo un impatto finanziario o di mercato minimo.

El 24 de junio de 2025, Southside Bancshares Inc. (SBSI) present贸 un Formulario 4 reportando una peque帽a transacci贸n interna realizada por la Directora de Banca, Sherri Anthony. El 20 de junio de 2025, Anthony vendi贸 121 acciones comunes a un precio promedio de 27,97 $ bajo el c贸digo de transacci贸n F, que generalmente indica acciones retenidas para cubrir impuestos o costos de ejercicio. Tras la venta, posee directamente 2.937 acciones y mantiene indirectamente 550 acciones a trav茅s del ESOP de la empresa. No se divulgaron valores derivados ni transacciones adicionales.

La desinversi贸n representa una fracci贸n muy peque帽a tanto de la tenencia total del ejecutivo como del total de acciones de SBSI, lo que sugiere un impacto financiero o de mercado m铆nimo.

2025雲� 6鞗� 24鞚�, Southside Bancshares Inc. (SBSI)電� 斓滉碃鞚�頄夓眳鞛勳瀽 Sherri Anthony鞚� 靻岅窚氇� 雮措秬鞛� 瓯半灅毳� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟. 2025雲� 6鞗� 20鞚�, Anthony電� 瓯半灅 旖旊摐 F鞐� 霐半澕 韽夑窢 臧�瓴� 27.97雼煬鞐� 121欤�鞚� 氤错喌欤茧ゼ 觳橂秳頄堨溂氅�, 鞚措姅 鞚茧皹鞝侅溂搿� 靹戈笀 霕愲姅 頄夓偓 牍勳毄鞚� 於╇嫻頃橁赴 鞙勴暣 欤检嫕鞚� 氤措頃橂姅 瓴冹潉 鞚橂頃╇媹雼�. 毵る弰 頉� 攴鸽厐電� 歆侅爲鞝侅溂搿� 2,937欤�毳� 氤挫湢頃橁碃 鞛堨溂氅� 須岇偓 ESOP毳� 韱淀暣 臧勳爲鞝侅溂搿� 550欤�毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 韺岇儩 歃濌秾鞚措倶 於旉皜 瓯半灅電� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

鞚措矆 毵り皝鞚� 鞛勳洂鞚� 齑� 氤挫湢 欤检嫕瓿� SBSI 鞝勳泊 欤检嫕 靾橃潣 鞎勳＜ 鞛戩潃 鞚茧秬毳� 彀頃橂┌, 鞛鞝� 霕愲姅 鞁滌灔鞐� 氙胳箻電� 鞓來枼鞚� 瓯办潣 鞐嗠嫟瓿� 韺愲嫧霅╇媹雼�.

Le 24 juin 2025, Southside Bancshares Inc. (SBSI) a d茅pos茅 un formulaire 4 signalant une transaction interne mineure r茅alis茅e par la directrice bancaire Sherri Anthony. Le 20 juin 2025, Anthony a c茅d茅 121 actions ordinaires 脿 un prix moyen de 27,97 $ sous le code de transaction F, qui indique g茅n茅ralement des actions retenues pour couvrir les imp么ts ou les co没ts d鈥檈xercice. Apr猫s la vente, elle d茅tient directement 2 937 actions et indirectement 550 actions via le plan ESOP de la soci茅t茅. Aucune valeur d茅riv茅e ni transaction suppl茅mentaire n鈥檃 茅t茅 divulgu茅e.

La cession repr茅sente une tr猫s faible fraction tant des avoirs totaux de la dirigeante que du nombre total d鈥檃ctions de SBSI, sugg茅rant un impact financier ou de march茅 minimal.

Am 24. Juni 2025 reichte Southside Bancshares Inc. (SBSI) ein Formular 4 ein, das eine kleinere Insider-Transaktion der Chief Banking Officer Sherri Anthony meldet. Am 20. Juni 2025 ver盲u脽erte Anthony 121 Stammaktien zu einem Durchschnittspreis von 27,97 $ unter dem Transaktionscode F, der 眉blicherweise f眉r zur眉ckbehaltene Aktien zur Deckung von Steuern oder Aus眉bungskosten steht. Nach dem Verkauf besitzt sie direkt 2.937 Aktien und h盲lt indirekt 550 Aktien 眉ber den ESOP des Unternehmens. Es wurden keine Derivate oder weiteren Transaktionen offengelegt.

Der Verkauf stellt einen sehr kleinen Anteil sowohl an den Gesamtbest盲nden der F眉hrungskraft als auch an der Gesamtzahl der SBSI-Aktien dar, was auf eine minimale finanzielle oder marktliche Auswirkung hindeutet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Novara Mark David
(Last) (First) (Middle)
12400 HIGH BLUFF DRIVE
(Street)
SAN DIEGO CA 92130
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TANDEM DIABETES CARE INC [ TNDM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & CHIEF COMMERCIAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/16/2025 M 7,414 A $0 32,609 D
Common Stock 06/16/2025 F(1) 3,846 D $20.76 28,763 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(2) (3) 06/16/2025 M 7,414 (4) (4) Common Stock 7,414 $0 44,488 D
Explanation of Responses:
1. Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
2. Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
3. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
4. RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Remarks:
/s/ Rachel Malina, Attorney-in-Fact for Mark D. Novara 06/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did the Southside Bancshares (SBSI) Form 4 filed on 24 June 2025 disclose?

It reported that Chief Banking Officer Sherri Anthony disposed of 121 common shares on 20 June 2025.

How many SBSI shares did Sherri Anthony dispose of in the reported transaction?

She disposed of 121 shares.

At what price were the SBSI shares disposed?

The shares were valued at $27.97 per share.

How many SBSI shares does Sherri Anthony own after the transaction?

She owns 2,937 shares directly and 550 shares indirectly via the ESOP.

What does transaction code "F" signify in a Form 4 filing?

Code F indicates shares withheld or surrendered to satisfy tax or exercise-price obligations.
Stock TNDM logo
Tandem Diabetes

NASDAQ:TNDM

TNDM Rankings

#3578 Ranked by Market Cap
N/A Ranked by Dividends
#27 Top Loser

TNDM Latest News

Aug 7, 2025
Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
Aug 6, 2025
Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance
Jul 31, 2025
Tandem Diabetes Care Announces Upcoming Conference Participation
Jul 1, 2025
Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025
Jun 20, 2025
Tandem Diabetes Care Announces t:slim X2鈩� Insulin Pump Compatibility with Abbott鈥檚 FreeStyle Libre庐 3 Plus Sensor in the United States

TNDM Latest SEC Filings

Aug 6, 2025
[10-Q] Tandem Diabetes Care, Inc. Quarterly Earnings Report
Aug 6, 2025
[8-K] Tandem Diabetes Care, Inc. Reports Material Event
Jul 17, 2025
[Form 4] Tandem Diabetes Care, Inc. Insider Trading Activity
Jun 18, 2025
[Form 4] Tandem Diabetes Care, Inc. Insider Trading Activity
Jun 18, 2025
[Form 4] Tandem Diabetes Care, Inc. Insider Trading Activity

TNDM Stock Data

1.01B
65.92M
0.95%
111.43%
15.16%
Medical Devices
Surgical & Medical Instruments & Apparatus
United States
San Diego